(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo ... Semaglutide is sold by Novo ...

New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and ...

Shares in Evotec jumped as much as 13.3% on Monday after regulatory filings showed private equity firm Triton had built an over 9% stake in the German drug development company.

A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose ...

Drugs like Ozempic and Wegovy have quickly become household names ... Another concern is “Ozempic face,” which can cause ...

Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...

Other possible serious side effects include inflammation of the pancreas, low blood sugar, allergic reactions, kidney problems, gallbladder issues, stomach paralysis, thyroid tumors, or cancer.

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

China's much-anticipated J-35A stealth aircraft, centrepiece of this week's Zhuhai air show, has been more than a decade in ...

Deaths from cardiovascular disease have surged among adults ages 25 to 64 living in rural areas, a new study shows.

The "Today" host underwent gastric bypass surgery in 2002 to help him lose weight.

Stroke was the fourth leading cause of death in the U.S. in 2023, according to the Centers for Disease Control and Prevention ...